Veritas In Silico Inc.

Direct answer

Veritas In Silico Inc. is publicly traded on JPX under the ticker 130A.T.

Veritas In Silico Inc. engages in the development of molecular medicine drugs. It provides a platform business for the discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. The company was founded by Shingo Nakamura on November 17, 2016 and is headquartered in Tokyo, Japan.

Can you invest in Veritas In Silico Inc.?

Yes. Veritas In Silico Inc. is publicly traded on JPX under the ticker 130A.T.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Veritas In Silico Inc.

Detailed equity research is provided by MarketSnap.